Literature DB >> 36214123

Health-Related Quality of Life in Older Patients With Heart Failure From Before to Early After Advanced Surgical Therapies: Findings From the SUSTAIN-IT Study.

Kathleen L Grady1, Andrew Kao2, John A Spertus3, Eileen Hsich4, Mary Amanda Dew5, Duc-Thinh Pham1, Justin Hartupee6, Michael Petty7, William Cotts8, Salpy V Pamboukian9, Francis D Pagani10, Brent Lampert11, Maryl Johnson12, Margaret Murray12, Koji Takeda13, Melana Yuzefpolskaya13, Scott Silvestry14, James K Kirklin9, Adin-Cristian Andrei1, Christian Elenbaas1, Abigail Baldridge1, Clyde Yancy1.   

Abstract

BACKGROUND: Restoring health-related quality of life (HRQOL) is a therapeutic goal for older patients with advanced heart failure. We aimed to describe change in HRQOL in older patients (60-80 years) awaiting heart transplantation (HT) with or without pretransplant mechanical circulatory support (MCS) or scheduled for long-term MCS, if ineligible for HT, from before to 6 months after these surgeries and identify factors associated with change.
METHODS: Patients from 13 US sites completed the EuroQol 5-dimension 3L questionnaire and Kansas City Cardiomyopathy Questionnaire-12 at baseline and 3 and 6 months after HT or long-term MCS. Analyses included univariate comparisons and multivariable linear regression.
RESULTS: Among 305 participants (cohort mean age=66.2±4.7 years, 78% male, 84% White, 55% New York Heart Association class IV), 161 underwent HT (n=68 with and n=93 without pretransplant MCS), and 144 received long-term MCS. From baseline to 3 months, EuroQol 5-dimension visual analog scale scores improved in HT patients without pretransplant MCS (54.5±24.3 versus 75.9±16.0, P<0.001) and long-term MCS patients (45.7±22.9 versus 66.2± 20.9, P <0.001); while Kansas City Cardiomyopathy Questionnaire-12 overall summary scores improved in all 3 groups (HT without pretransplant MCS: 47.2±20.9 versus 77.4±20.1, P <0.001; long-term MCS: 35.3±20.2 versus 58.6±22.0, P <0.001; and HT with pretransplant MCS: 58.3±23.6 versus 72.1±23.5, P=0.002). No further HRQOL improvement was found from 3 to 6 months. Factors most significantly associated with change in HRQOL, baseline 3 months, were right heart failure and 3-month New York Heart Association class, and 3 to 6 months, were 6-month New York Heart Association class and major bleeding.
CONCLUSIONS: In older heart failure patients, HRQOL improved from before to early after HT and long-term MCS. At 6 postoperative months, HRQOL of long-term MCS patients was lower than one or both HT groups. Understanding change in HRQOL from before to early after these surgeries may enhance decision-making and guide patient care. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02568930.

Entities:  

Keywords:  decision-making; heart failure; heart transplantation; mechanical circulatory support; quality of life

Mesh:

Year:  2022        PMID: 36214123      PMCID: PMC9561242          DOI: 10.1161/CIRCHEARTFAILURE.122.009579

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   10.447


  34 in total

1.  The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure.

Authors:  L P Cahalin; M A Mathier; M J Semigran; G W Dec; T G DiSalvo
Journal:  Chest       Date:  1996-08       Impact factor: 9.410

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  Older patients (age 65+) report better quality of life, psychological adjustment, and adherence than younger patients 5 years after heart transplant: A multisite study.

Authors:  Andrea M Shamaskin; Bruce D Rybarczyk; Edward Wang; Connie White-Williams; Edwin McGee; William Cotts; Kathleen L Grady
Journal:  J Heart Lung Transplant       Date:  2012-01-23       Impact factor: 10.247

4.  Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study.

Authors:  Xiaojuan Mi; Bradley G Hammill; Lesley H Curtis; Edward Chia-Cheng Lai; Soko Setoguchi
Journal:  Stat Med       Date:  2016-06-27       Impact factor: 2.373

5.  Improvement in quality of life in patients with heart failure who undergo transplantation.

Authors:  K L Grady; A Jalowiec; C White-Williams
Journal:  J Heart Lung Transplant       Date:  1996-08       Impact factor: 10.247

6.  Health-related quality of life in mechanical circulatory support: Development of a new conceptual model and items for self-administration.

Authors:  Kathleen L Grady; Susan Magasi; Elizabeth A Hahn; Sarah Buono; Edwin C McGee; Clyde Yancy
Journal:  J Heart Lung Transplant       Date:  2015-05-04       Impact factor: 10.247

Review 7.  Adaptation and coping in patients living with an LVAD: A metasynthesis.

Authors:  Martha Abshire; Roslyn Prichard; Mia Cajita; Michelle DiGiacomo; Cheryl Dennison Himmelfarb
Journal:  Heart Lung       Date:  2016-06-21       Impact factor: 2.210

8.  Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation.

Authors:  Kathleen L Grady; David Naftel; Lynne Stevenson; Mary Amanda Dew; Gerdi Weidner; Francis D Pagani; James K Kirklin; Susan Myers; Timothy Baldwin; James Young
Journal:  J Heart Lung Transplant       Date:  2013-10-23       Impact factor: 10.247

9.  Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.

Authors:  Eric S Weiss; Lois U Nwakanma; Nishant D Patel; David D Yuh
Journal:  J Heart Lung Transplant       Date:  2008-02       Impact factor: 10.247

10.  Health-Related Quality of Life in Older Patients With Advanced Heart Failure: Findings From the SUSTAIN-IT Study.

Authors:  Kathleen L Grady; Adin-Cristian Andrei; Christian Elenbaas; Anna Warzecha; Abigail Baldridge; Andrew Kao; John A Spertus; Duc-Thinh Pham; Mary Amanda Dew; Eileen Hsich; William Cotts; Justin Hartupee; Salpy V Pamboukian; Francis D Pagani; Michael Petty; Brent Lampert; Maryl Johnson; Margaret Murray; Koji Takeda; Melana Yuzefpolskaya; Scott Silvestry; James K Kirklin; Clyde Yancy
Journal:  J Am Heart Assoc       Date:  2022-02-12       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.